PROCEPT BioRobotics Quarterly Balance Sheets Chart
Quarterly
|
Annual
PROCEPT BioRobotics Quarterly Balance Sheets Table
Quarterly
|
Annual
| Unit: USD | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| assets | ||||||||||||||||
| current assets: | ||||||||||||||||
| cash and cash equivalents | 302,717,000 | 316,207,000 | 333,725,000 | 196,762,000 | 214,093,000 | 225,576,000 | 257,222,000 | 287,087,000 | 149,691,000 | 180,972,000 | 221,859,000 | 249,217,000 | 269,806,000 | 284,288,000 | 304,320,000 | 320,484,000 |
| accounts receivable | 80,817,000 | 79,267,000 | 69,048,000 | 58,917,000 | 56,081,000 | 48,376,000 | 34,622,000 | 33,173,000 | 20,642,000 | 15,272,000 | 12,838,000 | 10,894,000 | 6,992,000 | 4,464,000 | 6,353,000 | |
| inventory | 67,032,000 | 62,330,000 | 56,168,000 | 50,850,000 | 43,865,000 | 41,622,000 | 39,756,000 | 42,201,000 | 42,636,000 | 38,926,000 | 28,543,000 | 22,358,000 | 13,777,000 | 12,629,000 | 13,147,000 | 10,401,000 |
| prepaid expenses and other current assets | 7,501,000 | 7,987,000 | 8,453,000 | 6,321,000 | 5,017,000 | 5,907,000 | 5,213,000 | 3,981,000 | 3,739,000 | 4,263,000 | 6,175,000 | 4,519,000 | 3,860,000 | 4,070,000 | 4,242,000 | 2,232,000 |
| total current assets | 458,067,000 | 465,791,000 | 481,842,000 | 322,981,000 | 321,892,000 | 329,186,000 | 350,567,000 | 368,668,000 | 230,016,000 | 245,580,000 | 272,626,000 | 288,932,000 | 298,337,000 | 307,979,000 | 326,173,000 | 339,470,000 |
| restricted cash, non-current | 3,038,000 | 3,038,000 | 3,038,000 | 3,038,000 | 3,038,000 | 3,038,000 | 3,038,000 | 3,038,000 | 3,038,000 | |||||||
| property and equipment | 28,602,000 | 28,127,000 | 26,709,000 | 26,605,000 | 27,675,000 | 28,488,000 | 28,748,000 | 27,032,000 | 16,357,000 | 11,934,000 | 8,656,000 | 5,120,000 | 4,397,000 | 4,560,000 | 5,045,000 | 5,731,000 |
| operating lease right-of-use assets | 18,260,000 | 18,605,000 | 18,941,000 | 19,267,000 | 19,584,000 | 19,892,000 | 20,241,000 | 20,699,000 | 21,563,000 | 22,446,000 | 23,481,000 | 24,424,000 | 2,463,000 | 2,877,000 | 3,279,000 | 3,667,000 |
| intangible assets | 795,000 | 864,000 | 932,000 | 1,000,000 | 1,068,000 | 1,136,000 | 1,204,000 | 1,273,000 | 1,341,000 | 1,409,000 | 1,477,000 | 1,545,000 | 1,614,000 | 1,682,000 | 1,750,000 | 1,818,000 |
| other assets | 4,292,000 | 2,950,000 | 2,555,000 | 1,251,000 | 1,093,000 | 1,160,000 | 919,000 | 415,000 | 131,000 | 51,000 | 51,000 | 202,000 | 302,000 | |||
| total assets | 513,054,000 | 519,375,000 | 534,017,000 | 374,142,000 | 374,350,000 | 382,900,000 | 404,717,000 | 421,125,000 | 272,446,000 | 284,458,000 | 309,329,000 | 324,037,000 | 310,927,000 | 320,912,000 | 337,024,000 | 351,463,000 |
| liabilities and stockholders' equity | ||||||||||||||||
| current liabilities: | ||||||||||||||||
| accounts payable | 11,783,000 | 14,827,000 | 10,032,000 | 15,088,000 | 9,950,000 | 10,084,000 | 13,499,000 | 13,597,000 | 10,036,000 | 10,341,000 | 9,391,000 | 6,331,000 | 3,342,000 | 2,628,000 | 2,029,000 | 3,590,000 |
| accrued compensation | 16,302,000 | 14,976,000 | 21,537,000 | 18,834,000 | 14,882,000 | 11,469,000 | 16,885,000 | 13,265,000 | 9,949,000 | 7,408,000 | 13,447,000 | 10,284,000 | 6,906,000 | 4,586,000 | 6,475,000 | 4,875,000 |
| deferred revenue | 9,889,000 | 9,799,000 | 9,565,000 | 7,989,000 | 6,552,000 | 5,860,000 | 5,656,000 | 3,943,000 | 2,855,000 | 2,342,000 | 1,863,000 | 1,368,000 | 1,025,000 | 848,000 | ||
| operating lease, current | 2,059,000 | 1,983,000 | 1,839,000 | 1,769,000 | 1,701,000 | 1,702,000 | 2,354,000 | 2,998,000 | ||||||||
| loan facility liability | 2,000,000 | |||||||||||||||
| other current liabilities | 9,694,000 | 8,479,000 | 8,089,000 | 7,896,000 | 7,750,000 | 7,622,000 | 6,318,000 | 7,785,000 | 8,889,000 | 7,814,000 | 7,468,000 | 5,929,000 | 4,264,000 | 3,994,000 | 4,608,000 | 2,834,000 |
| total current liabilities | 49,727,000 | 52,064,000 | 53,133,000 | 53,646,000 | 42,845,000 | 38,650,000 | 45,927,000 | 41,356,000 | 35,945,000 | 32,504,000 | 35,290,000 | 27,359,000 | 18,633,000 | 14,757,000 | 16,242,000 | 14,179,000 |
| long-term debt | 51,524,000 | 51,498,000 | 51,472,000 | 51,438,000 | 51,404,000 | 51,371,000 | 51,339,000 | 51,307,000 | 51,275,000 | 51,241,000 | 51,213,000 | |||||
| operating lease, non-current | 25,784,000 | 26,332,000 | 27,361,000 | 27,843,000 | 28,315,000 | 26,730,000 | 27,135,000 | 25,782,000 | ||||||||
| other liabilities | 223,000 | 324,000 | 479,000 | 479,000 | 517,000 | |||||||||||
| total liabilities | 127,258,000 | 130,218,000 | 131,797,000 | 132,924,000 | 122,571,000 | 118,853,000 | 123,965,000 | 121,769,000 | 116,544,000 | 111,332,000 | 112,257,000 | 103,275,000 | 71,739,000 | 68,162,000 | 69,933,000 | 68,151,000 |
| commitments and contingencies | ||||||||||||||||
| stockholders’ equity: | ||||||||||||||||
| preferred stock, 0.00001 par value; | ||||||||||||||||
| authorized shares: 10,000 at june 30, 2025 and december 31, 2024 | ||||||||||||||||
| issued and outstanding shares: none at june 30, 2025 and december 31, 2024 | ||||||||||||||||
| common stock | ||||||||||||||||
| authorized shares: 300,000 at june 30, 2025 and december 31, 2024 | ||||||||||||||||
| issued and outstanding shares: 55,577 and 54,718 at june 30, 2025 and december 31, 2024, respectively | ||||||||||||||||
| additional paid-in capital | 976,240,000 | 959,656,000 | 948,091,000 | 768,365,000 | 757,935,000 | 744,463,000 | 735,240,000 | 726,428,000 | 558,352,000 | 550,270,000 | 545,753,000 | 541,048,000 | 537,046,000 | 531,509,000 | 528,666,000 | 526,526,000 |
| accumulated other comprehensive gain | -144,000 | 223,000 | 114,000 | -18,000 | -1,000 | 113,000 | 84,000 | |||||||||
| accumulated deficit | -590,300,000 | -570,722,000 | -545,985,000 | -527,129,000 | -506,155,000 | -480,529,000 | -454,572,000 | -427,066,000 | -402,444,000 | -377,159,000 | -348,675,000 | -320,503,000 | -297,890,000 | -278,706,000 | -261,521,000 | -243,173,000 |
| total stockholders’ equity | 385,796,000 | 389,157,000 | 402,220,000 | 241,218,000 | 251,779,000 | 264,047,000 | 280,752,000 | 299,356,000 | 155,902,000 | 173,126,000 | 197,072,000 | 220,762,000 | 239,188,000 | 252,750,000 | 267,091,000 | 283,312,000 |
| total liabilities and stockholders’ equity | 513,054,000 | 519,375,000 | 534,017,000 | 374,142,000 | 374,350,000 | 382,900,000 | 404,717,000 | 421,125,000 | 272,446,000 | 284,458,000 | 309,329,000 | 324,037,000 | 310,927,000 | 320,912,000 | ||
| authorized shares: 10,000 at march 31, 2025 and december 31, 2024 | ||||||||||||||||
| issued and outstanding shares: none at march 31, 2025 and december 31, 2024 | ||||||||||||||||
| authorized shares: 300,000 at march 31, 2025 and december 31, 2024 | ||||||||||||||||
| issued and outstanding shares: 55,278 and 54,718 at march 31, 2025 and december 31, 2024, respectively | ||||||||||||||||
| accounts receivable, net, | 83,496,000 | |||||||||||||||
| operating leases, current | 1,910,000 | 1,683,000 | 2,129,000 | |||||||||||||
| loan facility derivative liability | 2,000,000 | 2,000,000 | 1,942,000 | 1,859,000 | 1,832,000 | 1,805,000 | 1,779,000 | 1,609,000 | 1,570,000 | 1,533,000 | 1,496,000 | 1,460,000 | ||||
| operating leases, non-current | 26,868,000 | 26,182,000 | 23,975,000 | |||||||||||||
| other non-current liabilities | 324,000 | 517,000 | 200,000 | 200,000 | 200,000 | 200,000 | 200,000 | |||||||||
| authorized shares: 10,000 at december 31, 2024 and 2023, respectively | ||||||||||||||||
| issued and outstanding shares: none at december 31, 2024 and 2023 | ||||||||||||||||
| authorized shares: 300,000 at december 31, 2024 and 2023, respectively | ||||||||||||||||
| issued and outstanding shares: 54,718 and 50,771 at december 31, 2024 and 2023 | ||||||||||||||||
| authorized shares: 10,000 at september 30, 2024 and december 31, 2023 | ||||||||||||||||
| issued and outstanding shares: none at september 30, 2024 and december 31, 2023 | ||||||||||||||||
| authorized shares: 300,000 at september 30, 2024 and december 31, 2023 | ||||||||||||||||
| issued and outstanding shares: 52,146 and 50,771 at september 30, 2024 and december 31, 2023, respectively | ||||||||||||||||
| authorized shares: 10,000 at june 30, 2024 and december 31, 2023 | ||||||||||||||||
| issued and outstanding shares: none at june 30, 2024 and december 31, 2023 | ||||||||||||||||
| authorized shares: 300,000 at june 30, 2024 and december 31, 2023 | ||||||||||||||||
| issued and outstanding shares: 51,900 and 50,771 at june 30, 2024 and december 31, 2023, respectively | ||||||||||||||||
| loan facility derivative liability, current | 1,914,000 | 1,886,000 | ||||||||||||||
| authorized shares: 10,000 at march 31, 2024 and december 31, 2023 | ||||||||||||||||
| issued and outstanding shares: none at march 31, 2024 and december 31, 2023 | ||||||||||||||||
| authorized shares: 300,000 at march 31, 2024 and december 31, 2023 | ||||||||||||||||
| issued and outstanding shares: 51,393 and 50,771 at march 31, 2024 and december 31, 2023, respectively | ||||||||||||||||
| restricted cash, current | 777,000 | 777,000 | 777,000 | 777,000 | ||||||||||||
| loan facility derivative liability, non-current | ||||||||||||||||
| authorized shares: 10,000 at december 31, 2023 and 2022, respectively | ||||||||||||||||
| issued and outstanding shares: none at december 31, 2023 and 2022 | ||||||||||||||||
| authorized shares: 300,000 at december 31, 2023 and 2022, respectively | ||||||||||||||||
| issued and outstanding shares: 50,771 and 44,828 at december 31, 2023 and 2022, respectively | ||||||||||||||||
| restricted cash | 3,038,000 | 3,038,000 | 3,814,000 | 3,814,000 | 3,814,000 | 777,000 | 777,000 | |||||||||
| deferred revenue, current | 5,007,000 | 4,717,000 | ||||||||||||||
| deferred revenue, non-current | 517,000 | 357,000 | ||||||||||||||
| authorized shares: 10,000 at september 30, 2023 and december 31, 2022 | ||||||||||||||||
| issued and outstanding shares: none at september 30, 2023 and december 31, 2022 | ||||||||||||||||
| authorized shares: 300,000 at september 30, 2023 and december 31, 2022 | ||||||||||||||||
| issued and outstanding shares: 50,473 and 44,828 at september 30, 2023 and december 31, 2022, respectively | ||||||||||||||||
| accumulated other comprehensive loss | -6,000 | -6,000 | 15,000 | -6,000 | 217,000 | 32,000 | -53,000 | -54,000 | -41,000 | |||||||
| authorized shares: 10,000 at june 30, 2023 and december 31, 2022 | ||||||||||||||||
| issued and outstanding shares: none at june 30, 2023 and december 31, 2022 | ||||||||||||||||
| authorized shares: 300,000 at june 30, 2023 and december 31, 2022 | ||||||||||||||||
| issued and outstanding shares: 45,271 and 44,828 at june 30, 2023 and december 31, 2022, respectively | ||||||||||||||||
| authorized shares: 10,000 at march 31, 2023 and december 31, 2022 | ||||||||||||||||
| issued and outstanding shares: none at march 31, 2023 and december 31, 2022 | ||||||||||||||||
| authorized shares: 300,000 at march 31, 2023 and december 31, 2022 | ||||||||||||||||
| issued and outstanding shares: 45,009 and 44,828 at march 31, 2023 and december 31, 2022, respectively | ||||||||||||||||
| authorized shares: 10,000 at december 31, 2022 and 2021, respectively | ||||||||||||||||
| issued and outstanding shares: none at december 31, 2022 and 2021 | ||||||||||||||||
| authorized shares: 300,000 at december 31, 2022 and 2021, respectively | ||||||||||||||||
| issued and outstanding shares: 44,828 and 43,676 at december 31, 2022 and 2021, respectively | ||||||||||||||||
| operating lease – current portion | 2,473,000 | 2,258,000 | 2,181,000 | 2,105,000 | 2,032,000 | |||||||||||
| note payable – non-current portion | 50,692,000 | 50,507,000 | 50,254,000 | 50,004,000 | 49,762,000 | |||||||||||
| operating lease – non-current portion | 23,415,000 | 829,000 | 1,418,000 | 1,991,000 | 2,550,000 | |||||||||||
| authorized shares: 10,000 at september 30, 2022 and december 31, 2021 | ||||||||||||||||
| issued and outstanding shares: none at september 30, 2022 and december 31, 2021 | ||||||||||||||||
| authorized shares: 300,000 at september 30, 2022 and december 31, 2021 | ||||||||||||||||
| issued and outstanding shares: 44,714 and 43,676 at september 30, 2022 and december 31, 2021, respectively | ||||||||||||||||
| authorized shares: 10,000 at june 30, 2022 and december 31, 2021 | ||||||||||||||||
| issued and outstanding shares: none at june 30, 2022 and december 31, 2021 | ||||||||||||||||
| authorized shares: 300,000 at june 30, 2022 and december 31, 2021 | ||||||||||||||||
| issued and outstanding shares: 44,538 and 43,676 at june 30, 2022 and december 31, 2021, respectively | ||||||||||||||||
| authorized shares: 10,000 at march 31, 2022 and december 31, 2021 | ||||||||||||||||
| issued and outstanding shares: none at march 31, 2022 and december 31, 2021 | ||||||||||||||||
| authorized shares: 300,000 at march 31, 2022 and december 31, 2021 | ||||||||||||||||
| issued and outstanding shares: 44,077 and 43,676 at march 31, 2022 and december 31, 2021, respectively | ||||||||||||||||
| liabilities, redeemable convertible preferred stock and stockholders' equity | ||||||||||||||||
| note payable – current portion | ||||||||||||||||
| convertible preferred stock warrant liability | ||||||||||||||||
| redeemable convertible preferred stock | ||||||||||||||||
| authorized shares: none and 26,984 at and december 31, 2021 and 2020, respectively | ||||||||||||||||
| issued and outstanding shares: none and 25,402 at december 31, 2021 and 2020, respectively | ||||||||||||||||
| aggregate liquidation preference: none and 245,768 at december 31, 2021 and 2020, respectively | ||||||||||||||||
| stockholders’ equity | ||||||||||||||||
| authorized shares: 10,000 and none at december 31, 2021 and 2020, respectively | ||||||||||||||||
| issued and outstanding shares: none at december 31, 2021 and 2020 | ||||||||||||||||
| authorized shares: 300,000 and 40,000 at december 31, 2021 and 2020, respectively | ||||||||||||||||
| issued and outstanding shares: 43,676 and 4,713 at december 31, 2021 and 2020, respectively | ||||||||||||||||
| total liabilities, convertible redeemable preferred stock and stockholders’ equity | 337,024,000 | 351,463,000 | ||||||||||||||
| authorized shares: none and 26,984, at september 30, 2021 and december 31, 2020, respectively | ||||||||||||||||
| issued and outstanding shares: none and 25,402 at september 30, 2021 and december 31, 2020, respectively | ||||||||||||||||
| aggregate liquidation preference: none and 245,768 at september 30, 2021 and december 31, 2020, respectively | ||||||||||||||||
| authorized shares: 10,000 and none at september 30, 2021 and december 31, 2020, respectively | ||||||||||||||||
| issued and outstanding shares: none at september 30, 2021 and december 31, 2020 | ||||||||||||||||
| authorized shares: 300,000 and 40,000 at september 30, 2021 and december 31, 2020, respectively | ||||||||||||||||
| issued and outstanding shares: 43,472 and 4,713 at september 30, 2021 and december 31, 2020, respectively |
We provide you with 20 years of balance sheets for PROCEPT BioRobotics stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as asset and liabilities, payables and receivables, long debts and short debts, cash and inventories, expenses and profits. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of PROCEPT BioRobotics. Explore the full financial landscape of PROCEPT BioRobotics stock with our expertly curated balance sheets.
The information provided in this report about PROCEPT BioRobotics stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.